Skip to main content

Table 5 Nano material sterilization performance

From: Biological Stability of Water-Based Cutting Fluids: Progress and Application

Material

Size (nm)

MIC (mg/mL)

Zone of inhibition (mm)

Percentage inhibition

Ref. No.

AgNPS

  

8.1–36.4

 

[166]

50‒80

0.3×10−4‒0.047

S. aureus: 1.4‒2.0;

E. coli: 0.8‒1.8

 

[168]

  

9‒16

  
 

C.albicans:

MIC50=0.5,

MIC90=2;

S. cerevisiae: MIC50=4,

MIC90=32

  

[163]

10-25

5.8×10-3

  

[167]

n-Ag3O4

18

 

S. aureus: 13‒16;

P. Aeruginosa: 13‒16

 

[169]

f- Ag3O4

30

 

S. aureus: 7‒8;

P. Aeruginosa: 7‒11

 

n-NiO

16

 

S. aureus: 5‒6;

P. Aeruginosa: 6‒7

 

[158]

f-NiO

20

 

S. aureus: 7‒15;

P. Aeruginosa: 12‒17

 

Cu2O

 

MIC50=0.01

MIC90=0.055

  

[176]

SiO2

50‒100

B. subtilis: 6%‒2%;

E. coli: 4.5%‒1%

  

[171]

SiO2+Ag

16‒35

B. subtilis: 0.016‒0.500;

E. coli: 0.008‒0.25

  

[170]

GO

   

S. aureus: 97.3%

P. Aeruginosa: 48.6%

[42]

rGO

   

S. aureus: 67.7%

P. Aeruginosa: 93.3%

  1. Note: Staphylococcus aureus: S. aureus; Pseudomonas aeruginosa: P. Aeruginosa; Escherichia coli: E. coli; Bacillus subtilis: B. subtilis; candida albicans: C.albicans; Saccharomyces cerevisiae: S. cerevisiae; non-functionalized silver oxide nanoparticles referred as n-Ag3O4, functionalized nanoparticles as f-Ag3O4; non-functionalized nickel oxide nano-particles are referred to as n-NiO, functionalized nickel oxide nanoparticles as f-NiO; graphene oxide: GO; reduced GO: rGO